All stock lists
Interpace Biosciences, Inc. (OTC:IDXG)
US · Delayed Price · Currency is USD
Healthcare · Medical - Diagnostics & Research
5.50-1.00 (-15.38%)
Market cap
$32.5M
Health Score
Analyst consensus
Listed since
May 20, 1998
Website
Insider Score
––Not scored
IDXG Insider Score
Insiders here have filed 3 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
IDXG Stock Insider Trading Activity
IDXG stock’s insider trading shows no open-market insider trades by company insiders over the last 6 months.
Not enough price history.
Insider Trading Activity (Form 4 Filings)
An insider trade occurs when an individual that has non-public information about a company buys or sells shares of that company’s stock. Examples of insiders include a company’s executive officers (CEO, CFO, COO), its board of directors, and its major shareholders. Insiders are required to submit their trading activity to the SEC through Form 4 filings.
| Insider | Action | Shares | Avg Cost | Total | Δ Holdings | Held After | Date | Grade | Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Burnell Thomas W. CEO | Option exercise | 1,966,763 | — | — | 2775% | 2,037,645 | Aug 20, 2026 | — | Form 4 |
| Burnell Thomas W. CEO | Tax withheld | 581,718 | $1.61 | $936.57K | 28.5% | 1,455,927 | Aug 20, 2026 | — | Form 4 |
| McCarthy Christopher CFO | Option exercise | 277,009 | — | — | 592% | 323,800 | Aug 20, 2026 | — | Form 4 |
| 1315 Capital II, L.P. Other | Converted | 9,405,941 | $2.02 | $19.00M | New | 9,405,941 | Jan 20, 2026 | — | Form 4 |
| Ampersand 2018 Limited Partnership Other | Converted | 13,861,386 | $2.02 | $28.00M | New | 13,861,386 | Jan 20, 2026 | — | Form 4 |
What these mean— the action is the SEC’s own Form 4 transaction code. Only a buy or a sell is an open-market trade; the rest are transfers, awards and exercises, which is why they carry no price.
- Tax withheld (F) — Shares withheld to pay tax or an exercise price
- Option exercise (M) — Exercise or conversion of an exempt derivative
- Converted (C) — Conversion of a derivative security into shares
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.